PDL BioPharma, Inc. Convertible Notes Payable, Noncurrent
PDL BioPharma, Inc. had Convertible Notes Payable, Noncurrent of $13.51 million as of 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes Payable, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2021-03-29
- 2020-06-30: Convertible Notes Payable, Noncurrent $13.51M.
- 2020-03-31: Convertible Notes Payable, Noncurrent $13.30M.
- 2019-12-31: Convertible Notes Payable, Noncurrent $27.25M.
- 2019-09-30: Convertible Notes Payable, Noncurrent $132.48M.
| Period end | Convertible Notes Payable, Noncurrent | Convertible Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2020-06-30 | $13.51M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $13.30M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $27.25M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $132.48M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $128.52M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $126.57M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $124.64M 8-K · filed 2020-06-29 | |
| 2018-09-30 | $122.78M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $120.94M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $119.17M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $117.42M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $115.72M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $114.04M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $112.43M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $232.44M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $234.90M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $232.85M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $230.85M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $228.86M 10-K · filed 2017-03-01 | $232.84M 10-K · filed 2016-02-23 |
| 2015-09-30 | $281.58M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $279.75M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $277.98M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $276.23M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $274.51M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $272.82M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | $270.94M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $0.00 10-K · filed 2015-02-23 | |
| 2013-09-30 | $147.01M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $145.80M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $312.61M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $309.95M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $307.34M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $304.77M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $302.24M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $316.62M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $315.37M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $314.14M 10-Q · filed 2011-07-29 | |
| 2011-03-31 | $177.14M 10-Q · filed 2011-04-28 | |
| 2010-12-31 | $310.43M 10-K · filed 2012-02-23 | |
| 2010-09-30 | $227.99M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $228.00M 10-Q · filed 2010-07-29 | |
| 2009-12-31 | $228.00M 10-K · filed 2011-03-01 |